object
Zepbound
Eli Lilly's tirzepatide-based drug for chronic weight management targeting GLP-1 and GIP receptors.
Most often with
- organisationNovo Nordisk 3
- objectMounjaro 3
- organisationU.S. Food and Drug Administration 2
- organisationEli Lilly and Company 2
- organisationBMO Capital Markets 2
- objectWegovy 2
- objectretatrutide 2
- objectOzempic 2
- workJAMA Ophthalmology 1
- workClinicalTrials.gov 1
- placeUnited States 1
- placeUK 1
- placeNew Delhi 1
- placeMilan 1
- placeIndiana 1
- placeBasel 1